Novartis | NOVN

Stock Price
116.34
Daily Change
-1.72 -1.46%
Monthly
-11.41%
Yearly
10.57%
Q4 Forecast
113.98

EPS Reference Time Actual Consensus Previous
2026-07-21 FY2026Q2 2.41 2.42
2026-04-28 FY2026Q1 1.99 2.28
2026-04-02 FY2025Q4 2.03 1.98
2025-10-28 FY2025Q3 2.04 1.58
2025-07-17 FY2025Q2 AM 2.42 1.97



Peers Price Chg Day Year Date
AbbVie 262.82 2.89 1.11% 12.36% Oct/02
Alcon AG 52.84 -0.02 -0.04% -13.86% Oct/02
Almirall 10.22 0.02 0.20% -14.41% Oct/02
Amgen 403.04 -4.23 -1.04% 35.30% Oct/02
Autolus Therapeutics Ltd 1.78 -0.07 -3.78% 10.56% Oct/02
AstraZeneca 11,870.00 -162.00 -1.35% -6.17% Oct/02
Bayer 44.94 -0.46 -1.01% 55.77% Oct/02
Biogen 219.88 -2.94 -1.32% 37.53% Oct/02
Bristol-Myers Squibb 61.15 -0.31 -0.50% 34.54% Oct/02
Fresenius Medical Care 39.55 -0.13 -0.33% -13.21% Oct/02

Indexes Price Day Year Date
CH20 13661 38.07 0.28% 9.22% Oct/02
EU600 631 4.70 0.75% 10.68% Oct/02

Novartis traded at 116.34 this Friday October 2nd, decreasing 1.72 or 1.46 percent since the previous trading session. Looking back, over the last four weeks, Novartis lost 11.41 percent. Over the last 12 months, its price rose by 10.57 percent. Looking ahead, we forecast Novartis to be priced at 113.98 by the end of this quarter and at 107.18 in one year, according to Trading Economics global macro models projections and analysts expectations.

Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.



News Stream
Novartis Stock Price Hits All-time High
Novartis shares increased to an all-time high of 131.62 CHF. Over the past 4 weeks, Novartis gained 5.69%, and in the last 12 months, it increased 30.02%.
2026-09-01
Novartis Stock Price Hits All-time High
Novartis shares increased to an all-time high of 131.60 CHF. Over the past 4 weeks, Novartis gained 13.16%, and in the last 12 months, it increased 32.71%.
2026-07-02
Novartis Stock Price Hits All-time High
Novartis shares increased to an all-time high of 117.46 CHF. Over the past 4 weeks, Novartis gained 5.76%, and in the last 12 months, it increased 20.06%.
2026-02-02